An inherited heteroplasmic mutation in mitochondrial gene COI in a patient with prostate cancer alters reactive oxygen, reactive nitrogen and proliferation

RS Arnold, Q Sun, CQ Sun, JC Richards…�- BioMed research�…, 2013 - Wiley Online Library
RS Arnold, Q Sun, CQ Sun, JC Richards, SO′ Hearn, AO Osunkoya, DC Wallace…
BioMed research international, 2013Wiley Online Library
Mitochondrial DNA (mtDNA) mutations have been found in many cancers but the
physiological derangements caused by such mutations have remained elusive. Prostate
cancer is associated with both inherited and somatic mutations in the cytochrome c oxidase
(COI) gene. We present a prostate cancer patient‐derived rare heteroplasmic mutation of
this gene, part of mitochondrial respiratory complex IV. Functional studies indicate that this
mutation leads to the simultaneous decrease in cytochrome oxidation, increase in reactive�…
Mitochondrial DNA (mtDNA) mutations have been found in many cancers but the physiological derangements caused by such mutations have remained elusive. Prostate cancer is associated with both inherited and somatic mutations in the cytochrome c oxidase (COI) gene. We present a prostate cancer patient‐derived rare heteroplasmic mutation of this gene, part of mitochondrial respiratory complex IV. Functional studies indicate that this mutation leads to the simultaneous decrease in cytochrome oxidation, increase in reactive oxygen, and increased reactive nitrogen. These data suggest that mitochondrial DNA mutations resulting in increased reactive oxygen and reactive nitrogen generation may be involved in prostate cancer biology.
Wiley Online Library